Critics Skeptical of USDA Biotech Meetings

News Critics Skeptical of USDA Biotech Meetings AUTHOR:DANIEL GROSSMAN Date: FEBRUARY 08, 1988 WASHINGTON - The Department of Agriculture is hoping that a series of meetings this spring will demonstrate its desire to learn more about biotechnology research and strengthen its role in federal regulatory efforts. But some observers view the four regional conferences as a slick way to promote existing programs. "It seems like a lot of this business is a cynical way of getting public approval fo

Written byDaniel Grossman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

News

WASHINGTON - The Department of Agriculture is hoping that a series of meetings this spring will demonstrate its desire to learn more about biotechnology research and strengthen its role in federal regulatory efforts. But some observers view the four regional conferences as a slick way to promote existing programs.

"It seems like a lot of this business is a cynical way of getting public approval for doing what they want to do," said Robert Stevenson, director of the American Type Culture Collection, which maintains a germ plasma bank. Stevenson, who last spring attended a national conference on public conception of biotechnology that USDA sponsored, said he and others were disturbed by the uncritical attitudes toward USDA policies at that meeting.

Ron Buckhalt, director of USDA's public liaison office, defended the upcoming conferences which will feature scientists, journalists, industrial leaders and government officials, "There is a need for an informed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies